Celestial Biolabs to launch patented anti-diabetic product

13 Jan 2015 Evaluate

Celestial Biolabs, a Hyderabad based Bio-pharmaceutical Company, is set to launch its latest anti-diabetic product which is expected to be a breakthrough in research and in the management of Diabetes.

Through in-house research on the anti-diabetic activities of macro algal bio-active compounds in ‘streptozotocin’ induced diabetic models has shown to be safe from acute and chronic toxicity on experimental subjects. The company is in the process of launching this natural sea based 100% vegetarian product tentatively by April 2015.

Incidentally, the GMP & ISO 9001-2008 certified, public listed company’s Research and Developmental activities have been recognized by the Department of Science and Industrial Research (DSIR), Ministry of Science and Technology, Government of India, New Delhi.

Celestial Biolabs is currently engaged in the business of manufacturing and sale of bio-pharmaceutical products.

Celestial Biolabs Share Price

2.43 0.00 (0.00%)
11-Mar-2020 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.